Achieve Life Sciences (ACHV) Receivables (2010 - 2019)
Achieve Life Sciences' (ACHV) quarterly Receivables came in at $111000.0 in Q4 2023, up 5.71% YoY from $105000.0 in Q4 2022, and up 33.73% on a QoQ basis from $83000.0 in Q3 2023.
Powered by 
Analysis
Achieve Life Sciences (ACHV) Receivables (2010 - 2019) Analysis & Trends
Achieve Life Sciences (ACHV) has 13 years of Receivables data on file, last reported at $111000.0 in Q4 2023.
- Quarterly Receivables rose 5.71% year-over-year to $111000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $111000.0 (up 5.71% YoY) and the FY2023 annual result came in at $111000.0, up 5.71% from the prior year.
- Receivables rose to $111000.0 in Q4 2023, from $83000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $350000.0 in Q2 2023 to a low of $8000.0 in Q4 2019.
- A 4-year average of $150800.0 and a median of $128000.0 in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2019 — Receivables increased 14.29% — and 2023, when it tumbled 42.76%.
- Tracing ACHV's Receivables over 4 years: stood at $8000.0 in 2019, then soared by 1812.5% to $153000.0 in 2021, then slumped by 31.37% to $105000.0 in 2022, then increased by 5.71% to $111000.0 in 2023.
- The last three Receivables figures came in at $111000.0 (Q4 2023), $83000.0 (Q3 2023), and $350000.0 (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 160.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.06 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 8,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 124,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Sep 30, 2017 | 70,000.00 |
| Jun 30, 2017 | 241,000.00 |
| Mar 31, 2017 | 237,000.00 |
| Dec 31, 2016 | 510,000.00 |
| Dec 31, 2015 | 125,000.00 |
| Sep 30, 2015 | 61,000.00 |
| Jun 30, 2015 | 225,000.00 |
| Mar 31, 2015 | 1.63 Mn |
| Dec 31, 2014 | 5.79 Mn |
| Sep 30, 2014 | 4.85 Mn |
| Jun 30, 2014 | 4.95 Mn |
| Mar 31, 2014 | 8.78 Mn |
| Dec 31, 2013 | 8.88 Mn |
| Sep 30, 2013 | 10.22 Mn |